L. Royal Christensen: Difference between revisions
+ 3 categories; ±Category:American epidemiologists→Category:Epidemiologists using HotCat |
m some copy-editing |
||
| Line 1: | Line 1: | ||
'''L. Royal Christensen''' (1915–1997) was an American epidemiologist who, along with [[William S. Tillett]], won the 1949 [[Lasker Award]] for their work in showing that the [[enzyme]]s [[streptokinase]] and [[streptodornase]] can be used to treat disease.<ref name="NYTobit">{{cite news|url=http://www.nytimes.com/1997/03/28/us/l-royal-christensen-82-studied-enzymes.html|title=L. Royal Christensen, 82; Studied Enzymes|last=Saxon|first=Wolfgang|date=28 March 1997|work=The New York Times|page=17|accessdate=7 May 2014}}</ref> |
|||
Christensen was born In Everson, Washington.<ref name="NYTobit"/> He did his undergraduate work at University of Washington and received a PhD from St. Louis University in 1941.<ref name="NYTobit"/> He then taught microbiology at [[New York University School of Medicine]]-Bellevue Medical.<ref name="NYTobit"/> |
Christensen was born In Everson, Washington.<ref name="NYTobit"/> He did his undergraduate work at University of Washington and received a PhD from St. Louis University in 1941.<ref name="NYTobit"/> He then taught microbiology at [[New York University School of Medicine]]-Bellevue Medical.<ref name="NYTobit"/> |
||
His work involving both the enzyme streptokinase, which can help dissolve blood clots,<ref name="NYTobit"/> and purifying the enzyme streptodornase, which can be used to "dissolve secretions from infections" showed that they can be used to prevent the necessity of surgical removal of infections, was recognized by the Lasker Award in 1949.<ref name="NYTobit"/> Described as [[Thrombolysis|thrombolytic therapy]], this treatment was named as one of the top 10 discoveries in [[cardiology]] in the 20th century.<ref>Tex Heart Inst J. 2002; 29(3): 164–171. |
His work involving both the enzyme streptokinase, which can help dissolve blood clots,<ref name="NYTobit"/> and purifying the enzyme streptodornase, which can be used to "dissolve secretions from infections" showed that they can be used to prevent the necessity of surgical removal of infections, was recognized by the Lasker Award in 1949.<ref name="NYTobit"/> Described as [[Thrombolysis|thrombolytic therapy]], this treatment was named as one of the top 10 discoveries in [[cardiology]] in the 20th century.<ref>Tex Heart Inst J. 2002; 29(3): 164–171. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC124754/ Cardiology's 10 Greatest Discoveries of the 20th Century] Nirav J. Mehta, MD and Ijaz A. Khan, </ref> |
||
PMCID: PMC124754 |
|||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC124754/ Cardiology's 10 Greatest Discoveries of the 20th Century] |
|||
Nirav J. Mehta, MD and Ijaz A. Khan, </ref> |
|||
In 1953 he became director of Berg Institute for Experimental Physiology.<ref name="NYTobit"/> |
In 1953 he became director of Berg Institute for Experimental Physiology.<ref name="NYTobit"/> |
||
He moved to Toronto in 1967 and began working for the Division of Laboratory Animal Science at the University of Toronto.<ref name="NYTobit"/> He founded the American Association of Laboratory Animal Science, serving first president.<ref name="NYTobit"/><ref name="Science1999">{{cite book|last=American Association for Laboratory Animal Science|first=|title=50 years of laboratory animal science|url=http://books.google.com/books?id=MkJWAAAAYAAJ|accessdate=7 May 2014|year=1999|publisher=American Association for Laboratory Animal Science}}</ref> |
He moved to Toronto in 1967 and began working for the Division of Laboratory Animal Science at the University of Toronto.<ref name="NYTobit"/> He founded the American Association of Laboratory Animal Science, serving first president.<ref name="NYTobit"/><ref name="Science1999">{{cite book|last=American Association for Laboratory Animal Science|first=|title=50 years of laboratory animal science|url=http://books.google.com/books?id=MkJWAAAAYAAJ|accessdate=7 May 2014|year=1999|publisher=American Association for Laboratory Animal Science}}</ref> |
||
| ⚫ | |||
| ⚫ | |||
{{Reflist}} |
{{Reflist}} |
||
{{Persondata |
{{Persondata |
||
Revision as of 13:34, 19 June 2015
L. Royal Christensen (1915–1997) was an American epidemiologist who, along with William S. Tillett, won the 1949 Lasker Award for their work in showing that the enzymes streptokinase and streptodornase can be used to treat disease.[1] Christensen was born In Everson, Washington.[1] He did his undergraduate work at University of Washington and received a PhD from St. Louis University in 1941.[1] He then taught microbiology at New York University School of Medicine-Bellevue Medical.[1]
His work involving both the enzyme streptokinase, which can help dissolve blood clots,[1] and purifying the enzyme streptodornase, which can be used to "dissolve secretions from infections" showed that they can be used to prevent the necessity of surgical removal of infections, was recognized by the Lasker Award in 1949.[1] Described as thrombolytic therapy, this treatment was named as one of the top 10 discoveries in cardiology in the 20th century.[2]
In 1953 he became director of Berg Institute for Experimental Physiology.[1]
He moved to Toronto in 1967 and began working for the Division of Laboratory Animal Science at the University of Toronto.[1] He founded the American Association of Laboratory Animal Science, serving first president.[1][3]
References
- ^ a b c d e f g h i Saxon, Wolfgang (28 March 1997). "L. Royal Christensen, 82; Studied Enzymes". The New York Times. p. 17. Retrieved 7 May 2014.
- ^ Tex Heart Inst J. 2002; 29(3): 164–171. Cardiology's 10 Greatest Discoveries of the 20th Century Nirav J. Mehta, MD and Ijaz A. Khan,
- ^ American Association for Laboratory Animal Science (1999). 50 years of laboratory animal science. American Association for Laboratory Animal Science. Retrieved 7 May 2014.
   | This article about an American scientist is a stub. You can help Wikipedia by expanding it. |